The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 30, 2015

Filed:

Mar. 15, 2012
Applicants:

Charles M. Perou, Carrboro, NC (US);

Matthew J. Ellis, St. Louis, MO (US);

Philip S. Bernard, Salt Lake City, UT (US);

Torsten O. Nielsen, North Vancouver, CA;

Inventors:

Charles M. Perou, Carrboro, NC (US);

Matthew J. Ellis, St. Louis, MO (US);

Philip S. Bernard, Salt Lake City, UT (US);

Torsten O. Nielsen, North Vancouver, CA;

Assignees:

The University of North Carolina at Chapel Hill, Chapel Hill, NC (US);

Washington University, St. Louis, MO (US);

University of Utah Research Foundation, Salt Lake City, UT (US);

British Columbia Cancer Agency Branch, Vancouver, British Columbia, CA;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/704 (2006.01); A61K 31/7042 (2006.01); A61K 45/06 (2006.01); A61K 31/513 (2006.01); A61K 31/675 (2006.01); C12Q 1/68 (2006.01);
U.S. Cl.
CPC ...
A61K 31/704 (2013.01); A61K 31/7042 (2013.01); A61K 45/06 (2013.01); A61K 31/513 (2013.01); A61K 31/675 (2013.01); C12Q 1/6886 (2013.01); C12Q 2600/106 (2013.01);
Abstract

The application describes methods for screening subjects with breast cancer to determine if the breast cancer will be responsive to a breast cancer therapy including an anthracycline. The application also describes methods for treating subjects with breast cancer by screening them for the likelihood of the effectiveness of treating the cancer with a therapy including anthracycline and administering the therapy in subjects when it is found that anthracycline is likely to be effective.


Find Patent Forward Citations

Loading…